We are live on ! Find out more
GCIA

Gabelli & Co Investment Advisers Portfolio holdings

AUM $674M
1-Year Est. Return 64.46%
This Fund
S&P 500
This Quarter Est. Return
+17.23%
1 Year Est. Return
+64.46%
3 Year Est. Return
+233.2%
5 Year Est. Return
+564.06%
10 Year Est. Return
+5,311.56%
AUM
$666M
AUM Growth
+$42.2M
Cap. Flow
+$14.7M
Cap. Flow %
2.21%
Top 10 Hldgs %
33.94%
Holding
342
New
69
Increased
39
Reduced
33
Closed
63

Top Sells

Rank Stock Value
1
K
Kellanova
K
+$30.8M
2
VRNA
Verona Pharma
VRNA
+$28.3M
3
SPR
Spirit AeroSystems
SPR
+$17.2M
4
ALE
Allete
ALE
+$15.8M
5
WNS
WNS Holdings
WNS
+$14.6M

Sector Composition

Rank Sector Weight
1 Communication Services 18.75%
2 Healthcare 18.39%
3 Technology 14.83%
4 Industrials 11.04%
5 Financials 9.99%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
DAY
1
DELISTED
Dayforce
DAY
$26.7M 4%
385,353
+282,958
+276% +$19.5M
FYBR
2
DELISTED
Frontier Communications
FYBR
$26.4M 3.97%
693,619
+51,150
+8% +$1.93M
GTLS
3
DELISTED
Chart Industries
GTLS
$26M 3.9%
126,034
+20,334
+19% +$4.12M
EA
4
DELISTED
Electronic Arts
EA
$25.8M 3.88%
126,300
+111,450
+751% +$22.5M
EXAS
5
DELISTED
Exact Sciences
EXAS
$23.6M 3.54%
+232,200
New +$18.6M
RNAM
6
DELISTED
Avidity Biosciences
RNAM
$21.9M 3.28%
+303,030
New +$19.6M
CDTX
7
DELISTED
Cidara Therapeutics
CDTX
$21.2M 3.18%
+95,805
New +$15.5M
HOLX
8
DELISTED
Hologic
HOLX
$18.8M 2.83%
+253,000
New +$18.5M
TXNM
9
TXNM Energy Inc
TXNM
$5.92B
$18.3M 2.75%
310,636
+24,300
+8% +$1.4M
GDV icon
10
Gabelli Dividend & Income Trust
GDV
$2.64B
$17.4M 2.61%
626,000
CYBR
11
DELISTED
CyberArk
CYBR
$16.3M 2.45%
36,525
-9,500
-21% -$4.57M
SEE
12
DELISTED
Sealed Air
SEE
$16.2M 2.44%
+391,779
New +$15.2M
CFLT
13
DELISTED
Confluent
CFLT
$15.7M 2.36%
+518,550
New +$12.7M
GDL
14
GDL Fund
GDL
$92.2M
$15.6M 2.35%
1,846,636
NSC icon
15
Norfolk Southern
NSC
$76.9B
$14.6M 2.2%
50,620
+16,720
+49% +$4.84M
FOX icon
16
Fox Class B
FOX
$23.2B
$14.5M 2.17%
222,911
-35,000
-14% -$2.04M
AL
17
DELISTED
Air Lease Corp
AL
$13.6M 2.04%
211,456
+28,100
+15% +$1.79M
WBD icon
18
Warner Bros
WBD
$66.2B
$12M 1.81%
417,850
+360,950
+634% +$8.44M
LBRDK icon
19
Liberty Broadband Class C
LBRDK
$5.32B
$10.6M 1.59%
217,290
+15,400
+8% +$801K
GLU
20
Gabelli Utility & Income Trust
GLU
$116M
$9.38M 1.41%
486,810
NGD
21
DELISTED
New Gold Inc
NGD
$8.35M 1.25%
+958,144
New +$7.22M
TGNA
22
DELISTED
TEGNA Inc
TGNA
$7.7M 1.16%
396,958
+85,937
+28% +$1.7M
ATXS
23
DELISTED
Astria Therapeutics
ATXS
$7.61M 1.14%
+581,550
New +$6.95M
KVUE icon
24
Kenvue
KVUE
$36.8B
$7.23M 1.09%
+418,950
New +$6.85M
FOLD
25
DELISTED
Amicus Therapeutics
FOLD
$6.92M 1.04%
+485,950
New +$4.77M

Similar funds

Gabelli & Co Investment Advisers's Q4 2025 Portfolio in Review

As of Q4 2025, Gabelli & Co Investment Advisers held 342 positions worth $666M, up 6.8% from $624M the previous quarter. Its ten largest holdings account for 34% of the portfolio.

Gabelli & Co Investment Advisers's Q4 2025 filing shows 69 new, 39 increased, 33 reduced and 63 closed positions. Its largest new stake was Avidity Biosciences: 303,030 shares worth $21.9M. The largest sale was Kellanova, an estimated $30.8M.

By sector, the portfolio is most concentrated in Communication Services at 19% of assets, up from 17% a quarter earlier, followed by Healthcare and Technology.

  • Gabelli & Co Investment Advisers's largest Q4 2025 buy was Avidity Biosciences: 303,030 shares worth $21.9M.
  • Gabelli & Co Investment Advisers added most to Electronic Arts in Q4 2025, an estimated $22.5M increase.
  • Gabelli & Co Investment Advisers's biggest Q4 2025 reduction was CyberArk, cutting an estimated $4.57M.
  • Gabelli & Co Investment Advisers fully exited Kellanova in Q4 2025, selling an estimated $30.8M.
  • Gabelli & Co Investment Advisers's ten largest holdings make up 34% of its $666M portfolio in Q4 2025.
  • Gabelli & Co Investment Advisers opened 69 new positions and closed 63 in Q4 2025.
  • Gabelli & Co Investment Advisers's portfolio value rose 6.8% quarter-over-quarter to $666M.

Based on Gabelli & Co Investment Advisers's 13F filing for Q4 2025, filed 5 Feb 2026.